Vedolizumab in Pediatric Ulcerative Colitis- Comparison With Infliximab
Clinical trial NCT06614387 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06614387
- Sponsor
- JAROSLAW KIERKUS
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2028-04-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.